Healthy Clinical Trial
— PROFILEOfficial title:
Energy Adaptations During Active Workstation Use: Strategy for Individualization of Active Desk Programs
Verified date | July 2023 |
Source | University Hospital, Clermont-Ferrand |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The recent literature has highlighting the importance of the time of SB and the level of physical activity (PA) as predictors of metabolic cardio risks. Now, sedentary lifestyles are well recognized as one of the causes of mortality. As with physical activity, a dose-response relationship appears to exist: mortality would increase with time spent in sedentary behaviors. However, this relationship would not be linear: the more the daily sitting time increases, the more the consequences on mortality are important. It is now well demonstrated that time spent in sedentary adult behaviour finds primarily its origin in the work, characterized by prolonged and uninterrupted periods of sitting. Many strategies have been settled to break the prolonged sitting time. The most promising one seem to be the use of active workstations (standing, walking, cycling, stepping) because they reduce sedentary time at work and increase physical activity with positive effects on the global health. However inter variability in energy response have been identified during a sit to stand allocation with subject "savers" profile showing an increase in energy expenditure while others categorized as "non-savers" increased significantly their energy expenditure between sitting and standing position. As others active workstation strategies exist, this study aim to first, better characterize energy response to posture and activity allocation (15min sit-15min stand-15min sit-15min low intensity cycling), secondly to identify parameters that could explain different energy profile.
Status | Completed |
Enrollment | 50 |
Est. completion date | June 29, 2023 |
Est. primary completion date | December 12, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 20 Years to 50 Years |
Eligibility | Inclusion Criteria: - Healthy volunteer, male or female, between 18 and 61 years old - Body mass index > 18,5 kg/m2 and = 25 kg/m2 - Able to provide informed consent to research participation - Registered in the French social security system Exclusion Criteria: - Subject using a sit-to-stand office desk or a swiss ball - Contact jobs (face-to-face with people) - Pregnant or breastfeeding women - Medical or surgical history determined by principal investigator to be not compatible with the study - Subject with cardiorespiratory and/or osteo-articular disorders limiting their ability to perform physical tests or the use of active offices - Subject with type 1 or type 2 diabetes treated with insulin - Subject with progressive cardiovascular or neoplastic disease. - Subject with a major infection within 3 months of inclusion. - Subject with known neuromuscular pathology: myopathy, myasthenia, rhabdomyolysis, paraplegia, hemiplegia - Subject with chronic or acute inflammatory pathology 3 months prior to inclusion |
Country | Name | City | State |
---|---|---|---|
France | CHU de Clermont-Ferrand | Clermont-Ferrand |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Clermont-Ferrand | Laboratory AME2P UR3533, Université d'Auvergne |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | energy expenditure | Using an indirect calorimetry device change in energy expenditure will be assed during the 1h posture /activity allocation (15min sitting, 15min standing, 15min sitting, 15 min low intensity cycling) | change from baseline to the experimental visit (Day 1) | |
Secondary | physical activity level (ActiGraph) | using acceleometry device (ActiGraph Gt3x) | during the 7 days following the experimental session | |
Secondary | physical activity level (ActivPAL) | using accelerometry (ActivPAL) | during the 7 days following the experimental session | |
Secondary | Body composition : fat mass and fat free mass | body composition will be assessed by bioelectrical impedance device (TANITA MC-780MA) | day 0 | |
Secondary | upper limb strength | will be assessed with handgrip for upper limb muscle | during the experimental session after energy expenditure assessment (Day 1) | |
Secondary | aerobic fitness | will be assessed with the Step Test 6 minutes | during the experimental session after energy expenditure assessment (day 1) | |
Secondary | lower limb strength | will be assessed with isokinetic dynamometer | during the experimental session after energy expenditure assessment (day1) | |
Secondary | eating profile with DEBQ questionnaire (Dutch Eating Behavior Questionnaire) | the questionnaire will identify with a scale (items to rank between never and always) three major factors influencing eating behavior "emotional , restrained and external eating". For all items score goes from 0 to 5pts and the lower score the better/healthier. | during the experimental session before energy expenditure assessment (day 1) | |
Secondary | eating profile with TFEQ questionnaire (Three-Factor Eating Questionnaire) | the questionnaire will identify with a scale (items to rank between never and always) three major eating profiles (cognitive restraint, disinhibition, hunger). For Items 1 to 16 score goes from 4 to 1pts, from items 17-21 score goes from 1 to 4 pts. Global score is calculated the lower the healthier. | during the experimental session before energy expenditure assessment (day 1) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |